130 related articles for article (PubMed ID: 2573443)
21. Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade.
Dahlöf B; Andrén L; Svensson A; Hansson L
J Hypertens Suppl; 1983 Dec; 1(2):112-5. PubMed ID: 6152739
[TBL] [Abstract][Full Text] [Related]
22. Indenolol kinetics versus pharmacodynamics in hypertension.
Mailland F; Groothold G; Poli A; Pantarotto C
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):567-74. PubMed ID: 2877127
[TBL] [Abstract][Full Text] [Related]
23. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
24. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
Reilly CS; Wood M; Koshakji RP; Wood AJ
Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
[TBL] [Abstract][Full Text] [Related]
25. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
[TBL] [Abstract][Full Text] [Related]
27. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.
Robb OJ; Webster J; Petrie JC; Harry JD; Young J
Br J Clin Pharmacol; 1988 Apr; 25(4):433-8. PubMed ID: 2898256
[TBL] [Abstract][Full Text] [Related]
28. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
[TBL] [Abstract][Full Text] [Related]
29. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
[TBL] [Abstract][Full Text] [Related]
30. Adimolol, a long acting beta-adrenoceptor blocker in man.
Elliott HL; Jones CR; Deighton NM; Meredith PA; Reid JL
Br J Clin Pharmacol; 1987 May; 23(5):511-21. PubMed ID: 2885022
[TBL] [Abstract][Full Text] [Related]
31. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
Franssen C; Wollersheim H; de Haan A; Thien T
J Clin Pharmacol; 1992 Jul; 32(7):652-9. PubMed ID: 1353506
[TBL] [Abstract][Full Text] [Related]
32. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
33. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
[TBL] [Abstract][Full Text] [Related]
34. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
Thulesius O; Gjöres JE; Berlin E
Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
[TBL] [Abstract][Full Text] [Related]
35. Haemodynamic effects of indenolol at rest and after a submaximal workload in essential hypertension.
Aiello C; Groothold G; Gualtieri S; Irace L; Marini IL; Perna B; Romano A
Eur J Clin Pharmacol; 1985; 28(5):501-5. PubMed ID: 3899670
[TBL] [Abstract][Full Text] [Related]
36. Effect of propranolol on sympathetically mediated leg vasoconstriction in humans.
Pellinger TK; Halliwill JR
J Physiol; 2007 Sep; 583(Pt 2):797-809. PubMed ID: 17627989
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
Willette RN; Mitchell MP; Ohlstein EH; Lukas MA; Ruffolo RR
Pharmacology; 1998 Jan; 56(1):30-6. PubMed ID: 9467185
[TBL] [Abstract][Full Text] [Related]
38. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
Tachikawa S; Takenaka T; Maeno H
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
[TBL] [Abstract][Full Text] [Related]
39. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
Zechel HJ
Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
[No Abstract] [Full Text] [Related]
40. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Pittner H
Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
